Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$74.68 - $85.82 $9.04 Million - $10.4 Million
121,081 New
121,081 $9.82 Million
Q3 2022

Nov 14, 2022

BUY
$80.24 - $95.27 $13.7 Million - $16.2 Million
170,510 New
170,510 $14.1 Million
Q2 2021

Aug 16, 2021

SELL
$105.44 - $127.98 $6.47 Million - $7.85 Million
-61,339 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$99.98 - $123.89 $3.83 Million - $4.74 Million
38,269 Added 165.88%
61,339 $6.61 Million
Q4 2020

Feb 16, 2021

BUY
$82.82 - $117.4 $1.91 Million - $2.71 Million
23,070 New
23,070 $2.71 Million
Q2 2020

Aug 14, 2020

SELL
$65.52 - $88.28 $2.34 Million - $3.15 Million
-35,682 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$64.99 - $88.5 $2.32 Million - $3.16 Million
35,682 New
35,682 $2.71 Million
Q3 2019

Nov 14, 2019

SELL
$52.55 - $63.28 $22.2 Million - $26.8 Million
-423,348 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$43.42 - $57.79 $6.73 Million - $8.96 Million
155,053 Added 57.79%
423,348 $23.8 Million
Q1 2019

May 15, 2019

SELL
$49.95 - $59.21 $42,357 - $50,210
-848 Reduced 0.32%
268,295 $14.6 Million
Q4 2018

Feb 14, 2019

BUY
$48.73 - $76.08 $12.5 Million - $19.6 Million
257,444 Added 2200.56%
269,143 $13.9 Million
Q3 2018

Nov 14, 2018

BUY
$66.51 - $74.55 $778,100 - $872,160
11,699 New
11,699 $838,000
Q2 2018

Aug 14, 2018

SELL
$62.77 - $73.47 $10.5 Million - $12.3 Million
-167,009 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$65.0 - $80.03 $6.66 Million - $8.2 Million
-102,403 Reduced 38.01%
167,009 $11 Million
Q4 2017

Feb 14, 2018

SELL
$53.89 - $72.36 $60.1 Million - $80.7 Million
-1,115,690 Reduced 80.55%
269,412 $19.5 Million
Q3 2017

Nov 14, 2017

BUY
$56.13 - $64.78 $77.7 Million - $89.7 Million
1,385,102
1,385,102 $82.3 Million

Others Institutions Holding DVA

About DAVITA INC.


  • Ticker DVA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 91,300,000
  • Market Cap $15.2B
  • Description
  • DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine lab...
More about DVA
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.